Our Services
Medical Information
Helpful Resources
Published on: 4/24/2026
Zepbound can be highly effective for weight management but often leads to declines in lean body mass, including muscle. This muscle loss results from a calorie deficit, lower protein intake and reduced activity and may warrant dose adjustments or alternative therapies to balance fat loss and muscle preservation.
See below for more on individual risk factors, muscle-saving nutrition and exercise strategies, monitoring techniques and whether switching medications might be right for you.
Zepbound is a newer prescription medication prescribed for weight management. As with many powerful weight-loss drugs, it not only reduces fat but can also lead to a decrease in lean body mass—including muscle. Understanding why does Zepbound cause muscle loss—and what you can do about it—helps you make informed choices about your treatment plan.
Zepbound acts on the brain's appetite centers, helping you feel full sooner and eat less. It also slows gastric emptying and alters how your body processes nutrients. These combined effects typically result in:
While fat loss is the main goal, lean mass (muscle and water) often declines alongside.
Muscle loss on Zepbound usually stems from several overlapping factors:
Calorie Deficit
• Eating fewer calories forces your body to draw on stored energy—both fat and muscle.
• Rapid weight loss often pulls more from lean tissue unless countered by diet and exercise.
Reduced Protein Intake
• Slower digestion or mild nausea may lead you to skip protein-rich meals.
• Without enough amino acids, your body can't maintain muscle tissue.
Metabolic Adaptations
• As you lose weight, resting metabolic rate declines—your body becomes more efficient, burning fewer calories at rest.
• Some of this efficiency comes from breaking down muscle, which uses more energy than fat.
Lower Physical Activity
• Side effects like fatigue or dizziness may reduce your motivation for workouts.
• Less resistance training means less muscle stimulation and maintenance.
Several clinical trials and post-marketing studies have explored body-composition changes with GLP-1 receptor agonists (the class Zepbound belongs to). Findings generally show:
These numbers can vary widely based on individual diet, exercise habits, age and baseline muscle mass.
Certain factors raise the chance of losing muscle on Zepbound:
If you fit one or more of these categories, you may want to pay extra attention to muscle-preserving strategies.
You don't have to accept muscle loss as inevitable. Consider these practical steps:
Regular check-ins will help you balance fat loss with muscle preservation:
Switching from Zepbound isn't a one-size-fits-all answer. Discuss these questions with your healthcare provider:
Any change in therapy requires close medical supervision to balance benefits and risks.
If you notice:
…you may need a deeper medical check. Before your appointment, you can use Ubie's Medically approved LLM Symptom Checker Chat Bot to document your symptoms and better understand what questions to ask your healthcare provider.
Always follow up with your doctor or a qualified healthcare professional for personalized advice.
Zepbound can be highly effective for weight loss, but some muscle loss often accompanies that success. By understanding why does Zepbound cause muscle loss, and by implementing targeted nutritional and exercise strategies, you can protect your lean mass. Before making any changes to your medication:
If you experience serious or life-threatening symptoms at any point, seek immediate medical attention. Always consult a healthcare professional before starting, stopping or switching medications.
(References)
* Sarpong EM, Reber C, Wu Y, Tang W, Zhang L, Lam RL, Haupt A, Nauck MA, Brown-Frandsen K, Coskun T, Thomas MK. Effect of tirzepatide on body composition in patients with type 2 diabetes and obesity: a post-hoc analysis of the SURPASS trials. Diabetes Obes Metab. 2023 Dec;25(12):3739-3747. doi: 10.1111/dom.15243. Epub 2023 Aug 24. PMID: 37620892.
* Urva S, Coskun T, Loh MT, Chang YC, Haupt A, Benson C, Sims H, Thomas MK, D'Alessio DA. Effect of Tirzepatide on Body Composition and Energy Expenditure in People With Type 2 Diabetes. Diabetes Care. 2023 Feb 1;46(2):374-383. doi: 10.2337/dc22-0940. Epub 2022 Dec 15. PMID: 36520770.
* Sloop KW, Coskun T, Thomas MK. Tirzepatide: A Dual GLP-1 and GIP Receptor Agonist with Novel Actions on Body Composition. Obes Med. 2023 Dec;41:100522. doi: 10.1016/j.obmed.2023.100522. Epub 2023 Sep 21. PMID: 37981504.
* Jastreboff AM, Apovian LZ, Parker EM, Kushner EJ, Heckman N, Dayananda N, Wadden TA, Goldman B, Horn DB, Neuwahl J, Rynders CA, Du Y, Gick J, McGrossin M, Larsen SM, Fujinari M, Yang B, Avandia-Kassir N, Bunck MC, Stefanski A. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022 Jul 21;387(3):205-216. doi: 10.1056/NEJMoa2206038. Epub 2022 Jun 4. PMID: 35658024.
* Wilding JPH, Batterham RA, Calanna S, Van Gaal MF, Han J, Klimek DL, Castillo MJ, Ahmad NN, Tsai LF, Cone MR, McGowan BM, Plastics A, Jastreboff AM, Makaronidis J, Frias JP, Lingvay I, Linetzky B, Montefusco L, Blodget C. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. N Engl J Med. 2022 Jul 21;387(3):217-229. doi: 10.1056/NEJMoa2206037. Epub 2022 Jun 4. PMID: 35658025.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.